IPM vs MAXN

The deterministic health profile is weak, highlighted by a Piotroski F-Score of 2/9 and a completely bearish technical trend (0/100). While the company exhibits astronomical year-over-year revenue growth (2091.60%) and maintains a very low debt-to-equity ratio (0.06), these are overshadowed by a chronic inability to meet earnings expectations, with 0 beats in the last four quarters and a massive average surprise of -439.98%. The disconnect between the single analyst's target price of $6.50 and the actual financial performance suggests a high-risk speculative profile rather than a value investment.

MAXN exhibits signs of severe financial distress, anchored by a Piotroski F-Score of 4/9 which barely maintains a 'stable' rating despite catastrophic fundamental decay. The company is operating with negative equity (Price/Book: -0.08) and a devastating negative gross margin of -137.52%, meaning it loses money on every unit sold. With revenue plummeting by 89.40% YoY and a critical Quick Ratio of 0.15, the company faces an imminent liquidity crisis. The 99.9% decline over five years suggests a near-total loss of shareholder value.